VISTN Vistin Pharma ASA

Ex dividend NOK 0.50 today

Ex dividend NOK 0.50 today

The shares in Vistin Pharma ASA will be traded ex dividend NOK 0.50 as from today, 06.11.2024.



EN
06/11/2024

Underlying

VISTNVistin Pharma ASA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Vistin Pharma ASA

 PRESS RELEASE
Free
VISTN Vistin Pharma A...

Ex dividend NOK 0.50 today

Ex dividend NOK 0.50 today The shares in Vistin Pharma ASA will be traded ex dividend NOK 0.50 as from today, 06.11.2024.

November 6, 2024 1 EN
 PRESS RELEASE
Free
VISTN Vistin Pharma A...

Vistin Pharma ASA: Third quarter and YTD 2024 financial results

Vistin Pharma ASA: Third quarter and YTD 2024 financial results Oslo, Norway, 31st of October 2024 Vistin Pharma ASA (VISTN) today announces the financial results for the third quarter of 2024. Revenue in the third quarter ended at MNOK 106 compared to MNOK 120 in Q3 2023. Sales volume in the quarter decreased compared to same quarter last year driven by lower sales volume, safety stock build and lower global Metformin prices. Revenue for first nine months of 2024 ended at MNOK 316 compared to MNOK 328 YTD last year. Third quarter EBITDA ended at record high MNOK 29 compared to MNOK 2...

October 31, 2024 1 EN
 PRESS RELEASE
Free
VISTN Vistin Pharma A...

Vistin Pharma ASA: Invitation to Q3 2024 conference call

Vistin Pharma ASA: Invitation to Q3 2024 conference call Oslo, Norway, 24 October 2024 Vistin Pharma ASA will release its third quarter and YTD 2024 results on Thursday 31st of October 2024. Vistin Pharma will host a conference call for all shareholders and interested parties at the same day; Thursday 31st of October at 08:30 CET. There will be a Q&A session following the management discussion. The conference call will be held in English. The third quarter conference call will be available via web and audio through the following access points: Webcast: Telephone conference (online reg...

October 24, 2024 1 EN
 PRESS RELEASE
Free
VISTN Vistin Pharma A...

Responsibility statement for first half year of 2024

Responsibility statement for first half year of 2024 Please find attached the first half 2024 financial report including the Responsibility Statement. ***** For further information, please contact: Alexander KarlsenCFO This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachment

October 21, 2024 1 EN
 PRESS RELEASE
Free
VISTN Vistin Pharma A...

Vistin Pharma ASA: Mandatory notification of trade

Vistin Pharma ASA: Mandatory notification of trade Saga Pure ASA has on 26 September 2024 purchased 50,000 shares in Vistin Pharma ASA at NOK 28.2 per share. After the transaction Saga Pure ASA has a holding of 700,000 shares, corresponding to 1.58% ownership.Saga Pure ASA is closely associated with board member Øystein Stray Spetalen.   This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachment

September 26, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch